Validation of a Computational Histology Artificial Intelligence-based Biomarker for BCG Treatment in Non-muscle-invasive Bladder Cancer in the ANZUP 1301 Randomized Phase 3 Trial.
Journal:
European urology
Published Date:
Oct 21, 2026
Abstract
No abstract available for this article.
Authors
Keywords
No keywords available for this article.
